Company intelligence / Profile preview

GRUMA

Grand Rapids, Michigan, United Statesgruma.com ↗

Ownership: Private
Employees: ~400
Development stage: Commercial

Overview

GRAM operates as a leading CDMO specializing in sterile injectable drug products. It provides fill-finish services for biologics, small molecules, and vaccines in liquid vials, lyophilized vials, syringes, and cartridges. The company supports pharmaceutical development from clinical trials through to commercial production with advanced aseptic manufacturing technology and regulatory compliance.

Modalities: BiologicSmall moleculeVaccine
Industry: Contract Manufacturing Organization

Partnerships

Partnerships with global pharmaceutical and biotechnology companies for contract manufacturing servicesCollaborations with device manufacturers on advanced drug delivery solutions such as wearable devices and auto-injectors

Beyond the preview

Go deeper on GRUMA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GRUMA.

Explore the full profile